Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls CIPROFLOXACIN TABLETS, USP, 500 mg, 100 Tablets (10 tablets per blister card. 10 blister cards per carton), Manufactured

Recalled January 28, 2015 · FDA recall D-0377-2015 · Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Hazard

CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices · FDA Class II

Units

11,650 cartons

Sold at

Nationwide and Puerto Rico.

Description

CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices

Product

CIPROFLOXACIN TABLETS, USP, 500 mg, 100 Tablets (10 tablets per blister card. 10 blister cards per carton), Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 51079-182-20.

Manufacturer(s)

Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →